Mr. Clement is a seasoned medical device veteran with 30+ years’ experience in the industry including as CEO of start-ups Pathway Medical and Cardiac Insight. Mr. Clement is responsible for bringing multiple medical devices to market over his career spanning Neurosurgery, Interventional Cardiology, Vascular Surgery, Gasteroenterology and Radiology.

Samuel Browd, MD, PhD is Assistant Professor of Neurological Surgery at the University of Washington and attending pediatric neurosurgeon at Seattle Children's Hospital. Dr. Browd performs over 100 operations / yr to treat hydrocephalus. He focuses on research of hydrocephalus. Dr. Browd is the lead site investigator for the Hydrocephalus Clinical Research Network (HCRN) at the UW and the Director of the Hydrocephalus Program at SCH.

Dr. Lutz is an Assistant Professor of Bioengineering at the University of Washington. He is an expert in microfluidic systems for biotechnology applications with expertise in medical diagnostics and devices to treat hydrocephalus. His projects have a translational focus, and generally address commercialization issues. He develops technology directed at identified problems and approaches that can be successfully translated to patients.

Ms. Amoss has 24+ years in the medical device industry, most recently as a consultant to small & mid-size companies. Previously, she served as SVP, Marketing & Strategic Development at Pathway Medical, and in multiple leadership roles with Spiration and ACS (Guidant). Ms. Amoss’ broad range of global management roles in market development, clinical trials, regulatory, and reimbursement makes her particularly valuable to early stage companies.